Personality and Mental Disorders in Patients with Substance-Related Disorders Admitted to Addiction Clinics in Hamadan in 2014

Alireza Rahimi, Mohammad Kazem Zarabian, Marzieh Nazaribadie, Mohammad Hasani, Ahmad Heidari Pahlavian
2016 Avicenna Journal of Neuro Psycho Physiology  
Objectives: This study aimed to assess and compare the mental and personality disorders among people with substance-related disorder. Methods: This cross sectional study was performed from September 2014 to March 2015 in Hamadan city, Iran. The population of this study was all people who referred to the addiction clinics and were consumers of opioids or methamphetamine. Each client was examined in biaxial axis and patients with mental health were studied in the first axis using the SCID test.
more » ... ng the SCID test. Also, in the second axis, the personality disorders were evaluated in the patients using the Minnesota multiphasic personality inventory (MMPI) test. Results: All the 103 patients participated in this study were males. The mean age of the patients was 9.13 ± 9.41 years. The results of the MMPI test revealed that schizoid, paranoid, and passive aggressive personality disorders were significantly higher in people with an opioid use disorder compared with the people who taking methamphetamine. However, an antisocial personality disorder in patients taking methamphetamine was more common than in patients who taking opioid. In patients taking opioids, based on the results of the SCID, depression with or without psychotic features, major depressive disorder (MDD) and panic disorder were significantly higher compared with patients taking methamphetamine. Conclusions: The Bipolar mood disorder, panic disorder, paranoid personality disorder, MDD with psychotic features and passive aggressive personality disorder were more prevalent in patient who taking opiate and the antisocial personality disorder, schizoid personality disorder, substance-induced mood disorder and somatoform disorder were more prevalent in patients taking methamphetamine.
doi:10.5812/ajnpp.46581 fatcat:warss6jaundnph2nuguonsph7q